Monitoring the response of patients with
β
David A. Mankoff; Lisa K. Dunnwald; Julie R. Gralow; Georgiana K. Ellis; Mariann
π
Article
π
1999
π
John Wiley and Sons
π
English
β 221 KB
π 2 views
## BACKGROUND. Mammographic and physical examination assessments of the response of locally advanced breast carcinoma (LABC) to neoadjuvant therapy have been shown to be inaccurate. The authors studied the feasibility and accuracy of [technetium 99m]-sestamibi (MIBI) for monitoring the response of